Search Within

David H Ilson

Formats
  1. Journal Article (209)
  2. Meeting Abstract (168)
  3. Book Section (20)
  4. Review (13)
  5. Editorial (9)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Miscellaneous (1)
  11. Research Letter (1)
Groups
  1. Department of Medicine (433)
  2. Gastrointestinal Oncology Service (433)
  3. Solid Tumor Oncology Division (433)
  4. Center for Pancreatic Cancer Research (186)
  5. Surgery (136)
  6. Survivorship Research (127)

More Groups

People
  1. David Kelsen (132)
  2. Geoffrey Ku (122)
  3. Yelena Janjigian (111)
  4. Marinela Capanu (65)
  5. Laura Tang (60)
  6. Manjit Bains (51)

More People

Years
  1. 2025 (5)
  2. 2024 (16)
  3. 2023 (24)
  4. 2022 (21)
  5. 2021 (22)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (135)
  2. Annals of Oncology (28)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Journal of the National Comprehensive Cancer Network (14)
  5. Annals of Surgical Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (137)
  2. Elsevier Inc. (57)
  3. Oxford University Press (41)
  4. Springer (32)
  5. Lippincott Williams & Wilkins (22)
  6. Wiley Blackwell (18)

More Publishers

Results (433)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality of life (QOL) for patients with esophageal cancer receiving trimodality therapy with induction chemotherapy, chemoradiation, and surgery: Results from CALGB 80803 (alliance)
    Meeting Abstract

    Goodman, K. A.; Dueck, A. C.; Fruth, B.; Noonan, A. M.; Shergill, A.; Bekaii-Saab, T. S.; O'Reilly, E. M.; Meyerhardt, J. A.; Ilson, D. H.; Deshields, T. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Final overall survival results from phase 3 SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
    Meeting Abstract

    Shitara, K.; Van Cutsem, E.; Lordick, F.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Xu, R. H.; Lonardi, S.; Yamaguchi, K.; Hung, Y. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery
    Journal Article

    Kachnic, L. A.; Winter, K.; Suntharalingam, M.; Ilson, D.; Konski, A.; Lloyd, S.; McAvoy, S. A.; Lad, T.; Olowokure, O. G.; Samson, P.; more...
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Top advances of the year: Gastroesophageal cancer
    Editorial

    Goodman, K. A.; Hotca, A.; Liu, M.; Strong, V. E.; Ilson, D. H.
    Cancer (2024)

    Fulltext@MSK | Save
  • Malignancies of the upper gastrointestinal tract
    Editorial

    Ilson, D. H.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Gastroesophageal adenocarcinomas with defective mismatch repair: Current knowledge and clinical management
    Review

    Strickland, M. R.; Lander, E. M.; Gibson, M. K.; Ilson, D. H.; Ajani, J. A.; Klempner, S. J.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with gastric cancer after conversion from positive to negative peritoneal cytology
    Meeting Abstract

    Ellis, R. J.; Dikken, J. L.; Schlick, C. J. R.; Jadeja, B.; Ilson, D. H.; Ku, G. Y.; Tang, L. H.; Brennan, M. F.; Strong, V. E.; Coit, D. G.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • How to use anti-PD-1 therapy in gastric cancer: The approach in the United States
    Review

    Ilson, D. H.
    Chinese Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save